Zevra Therapeutics (ZVRA) Interest Coverage Ratio Growth (1y) (2015 - 2026)
Zevra Therapeutics (ZVRA) Interest Coverage Ratio Growth (1y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
-76.51% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
-303.06% |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
18.06% |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
75.42% |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
67.94% |
| 10 |
Zevra Therapeutics |
796.95 Mn |
596.33 Mn |
34.30 Mn |
1,219.15% |
| Date | Value |
|---|
| Mar 31, 2026 |
1,219.15% |
| Dec 31, 2025 |
168.05% |
| Sep 30, 2025 |
117.10% |
| Jun 30, 2025 |
-213.55% |
| Mar 31, 2025 |
90.23% |
| Dec 31, 2024 |
64.95% |
| Sep 30, 2024 |
71.86% |
| Jun 30, 2024 |
64.47% |
| Mar 31, 2024 |
60.47% |
| Dec 31, 2023 |
27.88% |
| Dec 31, 2022 |
95.11% |
| Dec 31, 2021 |
-20,503.17% |
| Sep 30, 2021 |
-35,406.82% |
| Jun 30, 2021 |
16,729.21% |
| Mar 31, 2021 |
1,267.37% |
| Dec 31, 2020 |
25.62% |
| Sep 30, 2020 |
-138.96% |
| Jun 30, 2020 |
134.25% |
| Mar 31, 2020 |
67.61% |
| Dec 31, 2019 |
50.34% |
